SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA Grants Accelerated Approval to Nuvalent's Neladalkib

The FDA granted accelerated approval to Nuvalent's neladalkib for ALK-positive NSCLC.

GSK

Related stories